Bayamban, Baby Boy .
HRN: 24-86-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/18/2024
06/25/2024
IV
190mg
Q8
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes